These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16612420)

  • 1. Debate on the paper by David Vlahov & David D. Celentano.
    Vargas EV
    Cad Saude Publica; 2006 Apr; 22(4):722-3; author reply 730-1. PubMed ID: 16612420
    [No Abstract]   [Full Text] [Related]  

  • 2. Debate on the paper by David Vlahov & David D. Celentano. The double dimension of care and management of injecting drug users living with HIV/AIDS.
    Bastos FI; Boily MC
    Cad Saude Publica; 2006 Apr; 22(4):719-20; author reply 730-1. PubMed ID: 16612418
    [No Abstract]   [Full Text] [Related]  

  • 3. Debate on the paper by David Vlahov & David D. Celentano. HIV infection, injection drug users and bioethics.
    Palácios M
    Cad Saude Publica; 2006 Apr; 22(4):725-6; author reply 730-1. PubMed ID: 16612423
    [No Abstract]   [Full Text] [Related]  

  • 4. Debate on the paper by David Vlahov & David D. Celentano. Drug users and the HIV/AIDS epidemic: old problems, new perspectives.
    Monteiro S
    Cad Saude Publica; 2006 Apr; 22(4):724-5; author reply 730-1. PubMed ID: 16612422
    [No Abstract]   [Full Text] [Related]  

  • 5. Debate on the paper by David Vlahov & David D. Celentano.
    Kalichman A
    Cad Saude Publica; 2006 Apr; 22(4):727-8; author reply 730-1. PubMed ID: 16612424
    [No Abstract]   [Full Text] [Related]  

  • 6. Debate on the paper by David Vlahov & David D. Celentano.
    de Lima DB
    Cad Saude Publica; 2006 Apr; 22(4):723; author reply 730-1. PubMed ID: 16612421
    [No Abstract]   [Full Text] [Related]  

  • 7. Debate on the paper by David Vlahov & David D. Celentano. The question of technology transfer: how does that apply to Brazilian reality?
    Pechansky F
    Cad Saude Publica; 2006 Apr; 22(4):720-1; author reply 730-1. PubMed ID: 16612419
    [No Abstract]   [Full Text] [Related]  

  • 8. Debate on the paper by David Vlahov & David D. Celentano. Access to AIDS treatment: appropriateness and correctness in the pursuit of good practice.
    Ayres JR
    Cad Saude Publica; 2006 Apr; 22(4):728-30; author reply 730-1. PubMed ID: 16612425
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors associated with the response to antiretroviral therapy among HIV-infected patients with and without a history of injection drug use.
    Palepu A; Yip B; Miller C; Strathdee SA; O'Shaughnessy MV; Montaner JS; Hogg RS
    AIDS; 2001 Feb; 15(3):423-4. PubMed ID: 11273228
    [No Abstract]   [Full Text] [Related]  

  • 10. Cohort profile: the Canadian HIV-hepatitis C co-infection cohort study.
    Klein MB; Saeed S; Yang H; Cohen J; Conway B; Cooper C; Côté P; Cox J; Gill J; Haase D; Haider S; Montaner J; Pick N; Rachlis A; Rouleau D; Sandre R; Tyndall M; Walmsley S
    Int J Epidemiol; 2010 Oct; 39(5):1162-9. PubMed ID: 19786463
    [No Abstract]   [Full Text] [Related]  

  • 11. 'Do HIV-infected injecting drug users over-report adherence to highly active antiretroviral therapy?' A comparison between patients' self-reports and serum protease inhibitor concentrations in the French Manif 2000 cohort study.
    Duran S; Solas C; Spire B; Carrieri MP; Fuzibet JG; Costagliola D; Lacarelle B; Moatti JP;
    AIDS; 2001 May; 15(8):1075-7. PubMed ID: 11399998
    [No Abstract]   [Full Text] [Related]  

  • 12. When should we delay highly active antiretroviral therapy?
    Bangsberg DR; Moss A
    J Gen Intern Med; 1999 Jul; 14(7):446-8. PubMed ID: 10417605
    [No Abstract]   [Full Text] [Related]  

  • 13. Adherence and antiretroviral therapy in injection drug users.
    Sherer R
    JAMA; 1998 Aug; 280(6):567-8. PubMed ID: 9707152
    [No Abstract]   [Full Text] [Related]  

  • 14. Access to antiretroviral therapy in HIV-infected injection drug users.
    Antela A
    AIDS; 2001 Sep; 15(13):1727-8. PubMed ID: 11546949
    [No Abstract]   [Full Text] [Related]  

  • 15. Mortality among urban drug users and the impact of highly active antiretroviral therapy.
    Celentano DD
    Clin Infect Dis; 2005 Sep; 41(6):873-4. PubMed ID: 16107988
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention. HAART expansion leads to drop in new infections among infection drug users.
    AIDS Policy Law; 2010 Mar; 25(4):1. PubMed ID: 20480629
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV infection in IVDUs decreases with expanded HIV treatment coverage.
    AIDS Patient Care STDS; 2010 Apr; 24(4):266. PubMed ID: 20405530
    [No Abstract]   [Full Text] [Related]  

  • 18. Staging for antiretroviral therapy among HIV-infected drug users.
    Wood E; Hogg RS; Bonner S; Kerr T; Li K; Palepu A; Guillemi S; Schechter MT; Montaner JS
    JAMA; 2004 Sep; 292(10):1175-7. PubMed ID: 15353528
    [No Abstract]   [Full Text] [Related]  

  • 19. Validity of self-reported adherence among injection drug users.
    Kerr T; Hogg RS; Yip B; Tyndall MW; Montaner J; Wood E
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(4):157-9. PubMed ID: 18626123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of injecting drug use on the interruption of antiretroviral therapies.
    Muga R; Egea JM; Sanvisens A; Arnal J; Tural C; Tor J; Rey-Joly C
    J Epidemiol Community Health; 2004 Apr; 58(4):286-7. PubMed ID: 15026439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.